Table 5.
Major fracture | OR | 95% CI | P valuec |
Age | |||
<55 | 1 | ||
>=55 | 6.361 | 3.255-12.431 | <0.0001 |
Sex | |||
Male | 1 | ||
Female | 1.009 | 0.763-1.334 | <0.9497 |
FRAX-majora | 1.057 | 1.042-1.071 | <0.0001 |
MTHFR rs1801133 | |||
GG | 1 | ||
GA | 0.852 | 0.657-1.103 | 0.2241 |
AA | 1.198 | 0.78-1.84 | 0.4104 |
Hip fracture | OR | 95% CI | P valuec |
Age | |||
<55 | 1 | ||
>=55 | 8.075 | 1.981-32.917 | 0.0036 |
Sex | |||
Male | 1 | ||
Female | 0.635 | 0.403-0.999 | 0.0495 |
FRAX-hipb | 1.077 | 1.051-1.104 | <0.0001 |
MTHFR rs1801133 | |||
GG | 1 | ||
GA | 0.891 | 0.564-1.408 | 0.6211 |
AA | 1.031 | 0.462-2.303 | 0.9407 |
aFRAX-major risk exceeding 20% vs. FRAX-major risk below 20%.
bFRAX-hip risk exceeding 3% vs. FRAX-hip risk below 3%.
cBy logistic regression with adjustment of age, sex, and FRAX.